How to compare treatment plans? Personalized perspective
نویسندگان
چکیده
منابع مشابه
Personalized Treatment Plans with Multivariate Outcome Measures
In this work we propose a novel method for individualized treatment selection when the treatment response is multivariate. Our method covers any number of treatments and it can be applied for a broad set of models. The proposed method uses a rank aggregation technique to estimate an ordering of treatments based on ranked lists of treatment performance measures such as smooth conditional means a...
متن کاملHow to Compare Treebanks
Recent years have seen an increasing interest in developing standards for linguistic annotation, with a focus on the interoperability of the resources. This effort, however, requires a profound knowledge of the advantages and disadvantages of linguistic annotation schemes in order to avoid importing the flaws and weaknesses of existing encoding schemes into the new standards. This paper address...
متن کاملHow to compare biologic drugs.
This consensus document reviews the evidence on the evaluation of biological drugs. The main conclusions of the group are: a) the current evidence on biological comparisons is based on indirect comparisons and is generally unreliable and with important methodological limitations. Therefore, b) it is considered necessary to amend the regulatory directives in the sense of strongly favoring random...
متن کاملHow to Compare the Incomparable
A technique for deciding between two processes, one with cost (xA ,yA) and the second with cost (xB ,yB) where xA>xB and yA<yB and no further information is available, is derived, using dimensionand gauge-theory like arguments. The technique can be summarized as: If you can’t add them, multiply them.
متن کاملBuilding personalized treatment plans for early-stage colorectal cancer patients
We developed a series of models to predict the likelihood of recurrence and the response to chemotherapy for the personalized treatment of stage I and II colorectal cancer patients. A recurrence prediction model was developed from 235 stage I/II patients. The model successfully distinguished between high-risk and low-risk groups, with a hazard ratio of recurrence of 4.66 (p < 0.0001). More impo...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Reports of Practical Oncology & Radiotherapy
سال: 2015
ISSN: 1507-1367
DOI: 10.1016/j.rpor.2014.04.011